4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 970.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,500.00
  • 52 Week Low: 950.00
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 448
  • Market Cap: £150.72m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
87.04% above the market average87.04% above the market average87.04% above the market average87.04% above the market average87.04% above the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
93.74% above the market average93.74% above the market average93.74% above the market average93.74% above the market average93.74% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Price Book Ratio
83.93% below the market average83.93% below the market average83.93% below the market average83.93% below the market average83.93% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
29.67% below the market average29.67% below the market average29.67% below the market average29.67% below the market average29.67% below the market average
24.44% below the sector average24.44% below the sector average24.44% below the sector average24.44% below the sector average24.44% below the sector average
Price Chg 3m
75.23% below the market average75.23% below the market average75.23% below the market average75.23% below the market average75.23% below the market average
64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
17.58% below the market average17.58% below the market average17.58% below the market average17.58% below the market average17.58% below the market average
36.59% below the sector average36.59% below the sector average36.59% below the sector average36.59% below the sector average36.59% below the sector average
Momentum 20
78.73% below the market average78.73% below the market average78.73% below the market average78.73% below the market average78.73% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
94.39% below the market average94.39% below the market average94.39% below the market average94.39% below the market average94.39% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
54.4% below the market average54.4% below the market average54.4% below the market average54.4% below the market average54.4% below the market average
13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
82.03% below the market average82.03% below the market average82.03% below the market average82.03% below the market average82.03% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
Operating Profit Loss
84.83% below the market average84.83% below the market average84.83% below the market average84.83% below the market average84.83% below the market average
54.55% below the sector average54.55% below the sector average54.55% below the sector average54.55% below the sector average54.55% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average
36.59% above the sector average36.59% above the sector average36.59% above the sector average36.59% above the sector average36.59% above the sector average
Cash
46.30% above the market average46.30% above the market average46.30% above the market average46.30% above the market average46.30% above the market average
62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
19.40% above the market average19.40% above the market average19.40% above the market average19.40% above the market average19.40% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Buys 1y
71.36% above the market average71.36% above the market average71.36% above the market average71.36% above the market average71.36% above the market average
61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 970.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,500.00
52 Week Low 950.00
Volume 448
Shares Issued 15.54m
Market Cap £150.72m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.95% below the market average65.95% below the market average65.95% below the market average65.95% below the market average65.95% below the market average
6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average
Price Trend
54.50% above the market average54.50% above the market average54.50% above the market average54.50% above the market average54.50% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Income Not Available
Growth
59.06% above the market average59.06% above the market average59.06% above the market average59.06% above the market average59.06% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

4basebio Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
14:46 4 @ 989.00p
08:39 400 @ 990.00p
08:08 44 @ 989.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page